logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
E

Expert Opinion on Pharmacotherapy

IF2.7
Papers127
Citations6801
Journal Papers 127
Publication Date
delete
Povorcitinib for Hidradenitis suppurativa: a narrative review on clinical trial data with expert commentary
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-07-03
delete0
PREAI
deleteKherallah, Kenan; Chung, Claire S.; Ontiveros, Sharon; Riley, Julia M.; Shi, Vivian Y.; Hsiao, Jennifer L.; Lee, Katrina H.
deleteShare
deleteSave
Is bacterial lysate add-on therapy a cost-effective strategy for childhood asthma? Evidence from a Colombian economic model
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-07-03
delete0
PREAI
deleteBuendia, Jefferson Antonio; Buendia Sanchez, Juan Antonio
deleteShare
deleteSave
Essential elements for guiding patient segmentation in precision pharmacotherapy for rheumatoid arthritis: lessons up to 2025
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-24
delete0
PREAI
deleteSonomoto, Koshiro; Tanaka, Yoshiya
deleteShare
deleteSave
The complexities of the pharmacotherapeutic management of chronic hepatitis C virus infection in hepatocellular carcinoma patients
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-24
delete0
PREAI
deleteSchiano Moriello, Nicola; Pinchera, Biagio; Gentile, Ivan
deleteShare
deleteSave
Targeted treatment of anemia in myelofibrosis and the impact of JAK inhibitors
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-24
delete0
PREAI
deleteAl Noumani, Iman; Harrison, Claire
deleteShare
deleteSave
Innovative approaches for managing relapsed or refractory peripheral T-cell lymphoma
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete0
PREAI
deleteGrainger, Brian T.; Casan, Joshua; Abeyakoon, Chathuri; Jain, Salvia; Prince, H. Miles
deleteShare
deleteSave
The challenges and practical considerations with optimizing neonatal pharmacotherapy
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete0
PREAI
deleteTurner, M. A.
deleteShare
deleteSave
Evaluating once-weekly insulin efsitora alfa for adults with type 2 diabetes
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete0
PREAI
deleteRamachandran, Akshaya; Batra, Jaskaran; Desouza, Cyrus
deleteShare
deleteSave
Targeted small molecules in polymyalgia rheumatica: the emerging role of JAK inhibitors beyond glucocorticoids and DMARDs
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete0
PREAI
deleteGonzalez-Gay, Miguel Angel; Alvarez-Rubio, Miguel; de Benito-Verniere, Ana; Belhaj-Gandar, Mariam; Roca-Magnet, Maria; Vicente-Rabaneda, Esther F.; Castaneda, Santos
deleteShare
deleteSave
Evaluating linaclotide for the treatment of functional constipation in children and adolescents
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete1
PREAI
deleteLinares, Manuel; Saps, Miguel
deleteShare
deleteSave
The impact of state-of-the-art pharmacotherapy for malaria in infants: a breakthrough?
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete0
PREAI
deleteGrobusch, Martin Peter; Adegbite, Bayode Romeo; Hanscheid, Thomas; Gupta, Nitin
deleteShare
deleteSave
Pharmacotherapies for Gaucher disease: what's new on the horizon?
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-01
delete0
PREAI
deleteBhattiprolu, Maya; Kappler, Max; Han, Tae-Un; Henderson, Mark; Serlin, Yonatan; Sidransky, Ellen
deleteShare
deleteSave
Glucocorticoid therapy and risk of venous thromboembolism: a systematic review and meta-analysis with exploration of dose, duration, and route-specific effects
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-01
delete2
PREAI
deleteSrivali, Narat; De Giacomi, Federica
deleteShare
deleteSave
What is the emerging role of RNA interference in HBV cure strategies?
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-01
delete0
PREAI
deleteCargill, Zillah; Agarwal, Kosh
deleteShare
deleteSave
Acute severe ulcerative colitis: efficacy and safety of JAK inhibitors
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-01
delete0
PREAI
deleteBruno, Alessandro; Bencardino, Sarah; D'Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio
deleteShare
deleteSave
Orforglipron and the emergence of oral GLP-1 therapy for obesity: efficacy, safety, and clinical positioning
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-01
delete2
PREAI
deleteZaman, Wajid; Amin, Adnan
deleteShare
deleteSave
Pivmecillinam: past, present, and future
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-01
delete0
PREAI
deleteFrimodt-Moller, Niels; Hertz, Frederik Boetius
deleteShare
deleteSave
Oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancer title
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-01
delete1
PREAI
deleteEtessami, Julian David; Valenza, Carmine; Berton Giachetti, Pier Paolo Maria; Crimini, Edoardo; Ferraro, Emanuela; Marra, Antonio; Belli, Carmen; Minchella, Ida; Zagami, Paola; Curigliano, Giuseppe; Trapani, Dario
deleteShare
deleteSave
Pharmacotherapeutic approaches to treating postpartum depression: a focus on GABAA receptor positive allosteric modulators
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-01
delete0
PREAI
deleteStewart, Anne Louise; Towers, Eleanor Blair; Wenzel, Elizabeth S.; Payne, Jennifer L.
deleteShare
deleteSave
New perspectives in managing chronic pelvic pain in endometriosis: the role of GnRH antagonists versus dienogest
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-04-13
delete1
PREAI
deletePalumbo, Mario; Giampaolino, Pierluigi; Pellicano, Massimiliano; Graziano, Vincenzo; Bifulco, Giuseppe; Della Corte, Luigi
deleteShare
deleteSave